Yang Xueping, Li Taoran, Chen Xu, Zhang Huan, Liu Chao, Tao Chenchuang, Nie Hailiang
Key Laboratory of Public Health Safety of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, School of Public Health, Hebei University, Baoding, 071002, PR China.
Department of Statistics, Hebei University, Baoding, 071002, PR China.
Talanta. 2025 May 1;286:127471. doi: 10.1016/j.talanta.2024.127471. Epub 2024 Dec 27.
Human serum albumin (HSA) levels in serum and urine is a crucial biomarker for diagnosing liver and kidney diseases. HSA is used to treat various disorders in clinical practice and as an excipient in the production of vaccine or protein drug, ensuring its purity essential for patient safety. However, selective and sensitive detection of HSA remains challenging due to its structural similarity with bovine serum albumin (BSA) and the inherent complexity of biological matrices. This study presents a novel application of the tetraphenylethylene-indole (TPE-indo) fluorophore for the identification and quantification of HSA. The findings demonstrate that TPE-indo binds specifically to HSA in a 1:1 M ratio, thereby triggering its aggregation-induced emission (AIE) mechanism and producing a selective, sensitive, and rapid "turn-on" fluorescence response. The fluorescence intensity of TPE-indo exhibited minimal interference from proteins, amino acids, sugars, ions, and urine metabolites, and demonstrated a linear correlation with HSA concentration up to 60 μg/mL, with a limit of detection of 0.30 μg/mL. Furthermore, TPE-indo displays a markedly enhanced response to HSA in comparison to BSA, which can be ascribed to the distinct binding modes between TPE-indo and these two proteins. TPE-indo can be used to quantify HSA in serum, grade proteinuria samples, detect BSA adulteration in HSA samples, and real-time monitor HSA degradation processes. This study not only advances the development of efficient HSA detection methods but also highlights the significance of TPE-indo as a versatile tool for bioanalysis and clinical diagnosis.
血清和尿液中的人血清白蛋白(HSA)水平是诊断肝脏和肾脏疾病的关键生物标志物。在临床实践中,HSA被用于治疗各种疾病,并作为疫苗或蛋白质药物生产中的辅料,确保其纯度对患者安全至关重要。然而,由于HSA与牛血清白蛋白(BSA)结构相似,且生物基质具有内在复杂性,对HSA进行选择性和灵敏检测仍然具有挑战性。本研究提出了一种新型的四苯基乙烯-吲哚(TPE-吲哚)荧光团用于HSA的鉴定和定量。研究结果表明,TPE-吲哚以1:1的摩尔比与HSA特异性结合,从而触发其聚集诱导发光(AIE)机制,并产生选择性、灵敏且快速的“开启”荧光响应。TPE-吲哚的荧光强度受蛋白质、氨基酸、糖、离子和尿液代谢物的干扰极小,并且与高达60μg/mL的HSA浓度呈线性相关,检测限为0.30μg/mL。此外,与BSA相比,TPE-吲哚对HSA的响应明显增强,这可归因于TPE-吲哚与这两种蛋白质之间不同的结合模式。TPE-吲哚可用于定量血清中的HSA、分级蛋白尿样本、检测HSA样本中的BSA掺假以及实时监测HSA的降解过程。本研究不仅推动了高效HSA检测方法的发展,还突出了TPE-吲哚作为生物分析和临床诊断通用工具的重要性。